Nonlinear Pharmacokinetics
Nonlinear pharmacokinetics is a pharmacokinetic condition in which changes in plasma drug concentration are nonproportional to dose, resulting from saturation of drug-eliminating enzymes, transporters, or plasma protein-binding sites.
567
Publications
26.4K
Citations
2K
Authors
703
Institutions
Publications per year
2017–2026
63
567
A pharmacokinetic analysis program (multi) for microcomputer.
Kiyoshi Yamaoka, Yusuke Tanigawara, Terumichi Nakagawa et al. · Journal of Pharmacobio-Dynamics · 1981 · 2.5K citations · Full text
Masanori Ichise, Jeih‐San Liow, Jian‐Qiang Lu et al. · Journal of Cerebral Blood Flow & Metabolism · 2003 · 677 citations · Full text
1–5 of 567
2K
11
h-index
University at Buffalo, State University of New York, United States
11 publications · 664 citations
11
h-index
10
h-index
6
h-index
6
h-index
1–5 of 2K
703
University at Buffalo, State University of New York
Buffalo, United States
21 h-index
76 publications
4.5K citations
University of California, San Francisco
San Francisco, United States
13 h-index
41 publications
4.2K citations
University of Michigan
Ann Arbor, United States
12 h-index
57 publications
2.9K citations
University of Iowa
Iowa City, United States
11 h-index
29 publications
923 citations
The University of Tokyo
Tokyo, Japan
10 h-index
29 publications
1K citations
Inserm
Paris, France
10 h-index
27 publications
1.9K citations
University of Washington
Seattle, United States
8 h-index
24 publications
1.3K citations
Novartis (Switzerland)
Basel, Switzerland
8 h-index
12 publications
883 citations
1–8 of 703
CPT · 31 publications · 1.8K citations
23
h-index
26 publications · 1.1K citations
20
h-index
AAC · 24 publications · 1.4K citations
18
h-index
26 publications · 802 citations
17
h-index
Repository · 22 publications · 1.3K citations
17
h-index
1–5
See also Nonlinear Pharmacokinetics | |
|---|---|
Mechanistic Causes | |
Mathematical Models | Target-mediated Drug Distribution Physiological-based Pharmacokinetic Modeling Neural Ordinary Differential Equations |
Clinical Implications | Therapeutic Drug Monitoring Dose Individualization Dose Adjustment Criteria Safety Margin Nonlinear Exposure-response Relationships Model-based Dose Individualization Bayesian Forecasting |
Assessment Methods | Population Pharmacokinetics Liquid Chromatography-mass Spectrometry Compartmental Modeling Nonstationary Compartment Models Nonlinear Oral Pharmacokinetics Bayesian Inference |